Sinopharm: Net profit attributable to parent company in the first quarter was 459 million yuan, a year-on-year increase of 10.86%

stock analyst • • stock options

.appendQr_wrap{border:1px solid #E6E6E6;padding:8px;} .appendQr_normal{float:left;} .appendQr_normal img{width:74px;} .appendQr_normal_txt{float:left;font-size:20px;line-height:74px ;padding-left:20px;color:#333;} Massive information and accurate interpretation, all in Sina Finance APP .vip-class{margin-top: 40px;} .vip-class-cont{display: flex; align-items : flex-start; justify-content: space-between;} .vip-class-item{width: 264px;} .vip-class-pic{display: block; width: 100%;} .vip-class-text{ padding-top: 8px; line-height: 22px; font-size: 16px; max-height: 44px; overflow: hidden; word-break: break-all; display: -webkit-box; -webkit-box-orient: vertical; -webkit-line-clamp: 2;} .vip-class-text a, .vip-class-text a:visited{color: #000;} .vip-class-text a:hover{color: #3753a2 ;} @media screen and (max-width:1440px) { .vip-class-item {width: 200px;} } VIP course recommendations are loading… APP Exclusive Live Broadcast Previous Page Next Page 1/10 Popular Recommendations Close the Sina Finance official account to broadcast the latest financial information and videos 24 hours a day. For more fan benefits, scan the QR code to follow (sinafinance)

Sinopharm announced on April 25 that the company achieved operating income of 12.122 billion yuan in the first quarter, a year-on-year increase of 7.98%; net profit attributable to the parent company was 459 million yuan, a year-on-year increase of 10.86%; basic earnings per share was 0.6089 yuan.

Like (0)
stock analyststock analyst
Previous April 25, 2024 7:59 pm
Next April 25, 2024 7:59 pm

Related posts

  • Block, bulk deals get off to a brisk start in FY25

    Block and bulk deals have shown a phenomenal increase in the current fiscal year so far, with the combined sell-downs tripling from year ago to over ₹25,500 crore, as promoters and strategic investors took the opportunity to exit their investments in Indian companies.

    stock options May 7, 2024

  • Hindustan Construction raises ₹350 crore via rights issue

    Hindustan Construction Company has raised ₹350 crore through the rights issue. According to the company’s statement, the issue has been oversubscribed by 250 per cent, with the company receiving applications worth ₹877 crore (the balance being refunded to investors).

    stock options April 19, 2024

  • Aadhar Housing Finance, Indegene, TBO Tek set to drive primary market with ₹6,400 crore IPO blitz this week

    The primary market is gearing up for significant activity this week, with three companies — Blackstone-backed Aadhar Housing Finance, healthcare tech firm Indegene and travel distribution firm TBO Tek — poised to float IPOs aiming to collectively raise nearly ₹6,400 crore.

    stock options May 7, 2024

  • ETF closing comments丨Japanese stocks fell 2%, Nikkei ETF fell 2.8%

    Gelonghui April 25 | The three major A-share indexes had mixed gains and losses today. As of the close, the Shanghai Composite Index rose 0.27%, the Shenzhen Component Index rose 0.14%, the GEM Index fell 0.04%, and the Shanghai and Shenzhen Stock Exchange turnover was 773.4 billion yuan. , a decrease of 21.1 billion yuan from the previous day. Over 2,900 stocks in the two cities rose, with northbound funds buying 349 million yuan. On the market, PEEK materials, titanium dioxide, phosphorus chemicals, and weight-loss drug sectors were among the top gainers; kitchen and bathroom appliances, and national defense and military industry sectors were among the top losers.

    stock options April 25, 2024

  • Yiming Pharmaceutical (002826.SZ): Net profit in the first quarter was 27.8991 million yuan, a year-on-year increase of 233.58%

    Gelonghui April 25 | Yiming Pharmaceutical (002826.SZ) announced the first quarter report of 2024. The operating income during the reporting period was 160 million yuan, a year-on-year decrease of 6.42%; the net profit attributable to shareholders of the listed company was 27.8991 million yuan, a year-on-year increase. 233.58%; net profit excluding non-recurring gains and losses attributable to shareholders of listed companies was 1.77998 million yuan, a year-on-year decrease of 77.30%; basic earnings per share was 0.15 yuan.

    stock options April 25, 2024

  • Sensex ends marginally lower, Nifty holds steady

    Benchmark Sensex declined over 45 points in highly volatile trade on Wednesday, tracking weak Asian markets and continuous foreign fund outflows.

    stock options May 8, 2024